Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 26, 2025

The Long-Standing Problem of Proliferative Retinopathies: Current Understanding and Critical Cues.

View Full Paper
Ask AI
Bookmark
Share

Authors

MCMaurizio CammalleriPBPaola Bagnoli

Discussion

Loading...

Member takes

Overview

Review discusses advances in targeting retinal ischemia and neovessel proliferation in proliferative retinopathies, suggesting new therapeutic approaches.

Key Points

  • Proliferative retinopathies result from retinal ischemia and neovessel proliferation, leading to severe ocular complications.
  • Current treatment mainly involves anti-VEGF injections, but efficacy declines due to side effects over time.
  • Oxygen-induced retinopathy models help study proliferative retinopathies in rodents despite their short lifespan.
  • Emerging therapies aim to enhance treatment effectiveness by combining systemic approaches with anti-VEGF therapy.

Cite This Study

Cammalleri et al. (2025) studied this question.

synapsesocial.com/papers/689a0933e6551bb0af8ce559https://doi.org/10.3390/cells14141107
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Recent advances in treating age-related macular degeneration and diabetic retinopathy: Current therapies and emerging novel approaches2025
  2. 2Therapeutic strategies targeting ocular vasculopathies: Current advances and emerging challenges2025 · 5 citations
  3. 3Pathogenic mechanisms and treatment advances in proliferative vitreoretinopathy: A review2025
  4. 4Proliferative diabetic retinopathy subtypes defined by immune defense and endothelial mitochondrial dysfunction2025
  5. 5Non-invasive pharmacological advances in early retinopathy treatment: bioactive herbal compounds, polymer delivery systems, and computational bioprospecting of functional targets2025